Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
Trump Rescinds Biden AI EO, Shifts Development to Private Sector
The president signaled this week that the White House will center industry responsibility for AI leadership.
3m read -
AI FedLab
The Defense IT Summit will bring together federal and industry leaders to discuss AI in defense operations, CJADC2 and multi and hybrid cloud security.
Carahsoft Conference & Collaboration Center | 11493 Sunset Hills Rd. Reston, VA 20190 -
Digitizing Records for an AI-Driven Future
CMS and NARA are digitizing and standardizing data to enable AI, while also developing effective governance strategies to manage associated risks.
30m watch -
Data Drives the Future of Health Care
Federal data initiatives across the Department of Health and Human Services aim to improve health outcomes by enhancing data sharing, privacy and security across the health care ecosystem.
30m watch
